With a $128,500 grant over 2011-2013 from FRAXA Research Foundation, Drs. Bradley Alger and Ai-Hui Tang at the University of Maryland researched endocannabinoid pathways in Fragile X.
Read moreAlger, Bradley
Bradley Alger, PhD, Professor Emeritys at the University of Maryland School of Medicine, researches a wide range of neurophysiological functions and has a focus on endocannabinoids. Dr. Alger received a FRAXA Research Foundation grant in 2011 that researched potential treatment strategies for Fragile X syndrome via the endocannabinoid system.